During biopharmaceutical drug development, differential scanning calorimetry (DSC) is used to evaluate protein stability. The data provided by this established biophysical tool is employed to advance ...

In drug discovery and research projects, an important focus is the determination and characterization of binding interactions between proteins and low molecular weight (LMW) ligand interactions.

The characterization and measurement of interactions between low-molecular weight (LMW) ligands and proteins are essential in drug discovery. One of the most common issues faced during the ...

Malvern Instruments Ltd has announced that it has completed the acquisition of MicroCal from GE Healthcare Life Sciences and has also purchased the Archimedes particle characterization system from ...

Isothermal titration calorimetry (ITC) can measure heat emission or absorption during binding interactions between proteins and low-molecular weight (LMW) ligands, a focus area of drug discovery and ...

MicroCal has a 30-year history of developing and supplying easy-to-use microcalorimeters. These systems are used extensively to study proteins and other biomolecules in drug discovery and development.

Riverside Partners, based in Boston, MA, is pleased to announce the sale of its portfolio company, MicroCal, to GE Healthcare, a unit of General Electric Company (NYSE: GE). “The management team and ...

Malvern Instruments will acquire the MicroCal business from GE Healthcare Life Sciences. Malvern Instruments has entered into an agreement with GE Healthcare Life Sciences to acquire MicroCal, GE’s ...

Malvern Instruments acquired GE Healthcare Life Sciences' microcalorimetry business MicroCal. The analytical instrument manufacturer says the acquisition should be completed sometime in 2014's third ...

MicroCal ´ s proprietary technology, which is complementary to GE Healthcare ´ s Biacore platform, provides scientists with detailed information across several stages of the drug discovery process, ...